by Raynovich Rod | Nov 25, 2015 | Biopharmaceuticals
Slow But Steady Biotech Rally RNA Therapeutics-Duchenne Muscular Dystrophy (DMD) Despite some overhanging concerns about drug pricing and major setbacks from clinical trials like Clovis Oncology (CLVS) and BioMarin Pharmaceutical (BMRN) the sector looks like it wants...
by Raynovich Rod | Nov 13, 2015 | Biopharmaceuticals, Clinical Diagnostics and Tools
Update 11/16 PM Biotech Rally Underperforms Energy up 2.99% and Telecom up 1.81% The S&P and Dow rallied past Paris attack and terrorism concerns after an early morning stall. Biotechs underperformed weighed down by the Clovis Oncology (CLVS) NDA delay. The IBB...
by Raynovich Rod | Nov 9, 2015 | Biopharmaceuticals
Small Caps Hot, Large Caps Not Curis (CRIS) and Fibrocell Science (FCSC) Lead the Way Up Biotech stocks could not extend last month’s rally in choppy trading that left major indices up but off mid-week highs. The healthcare sector sold off on continued pricing...
by Raynovich Rod | Oct 23, 2015 | Biopharmaceuticals
General Issues from Bio Investor Forum See BIOtechNow for detailed articles on BIF#15 Biotech executives and investors came with a record 900 attendees to this annual event which presents key issues in the industry and offers a networking forum with 175 presenting...
by Raynovich Rod | Oct 22, 2015 | Biopharmaceuticals
Summary for the Week of Oct 19:Markets Up on Central Banks Easing;Techs Lead the Way IBB up 0.62%- 316.3 bottomed on Wednesday. QQQ up 4.3%- 112.78 up big Thursday and Friday. XBI down o.58%- 65.67 in choppy trading. XLI up 4%- 54.66 steady climb from Monday. XLV...
by Raynovich Rod | Oct 19, 2015 | Biopharmaceuticals
October 21 Update 9:45a EDT NASDAQ up 0.4% IBB up 1.57% 1:45p EDT Biotech Thrashing Continues-High Fliers Hit Hardest Healthcare stocks remain under attack with the XLV down 1.5% and the IBB down 1.6%.Healthcare is the sector loser down 2% while the Industrials are...
by Raynovich Rod | Oct 13, 2015 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals, Life Science ETF's and Mutual Funds
10/15 After the Close… XBI Up 7.26%…Green Screen…MOmentum is back Biotech stocks soared today in a broad rally showing a good appetite especially for small and mid-cap stocks. This could be a counter-trend rally in a biotech bear market but there is...
by Raynovich Rod | Sep 29, 2015 | Biopharmaceuticals
Another Rally from FED minutes…except biotech 10/8/15 … BIOTECH-Another test near 2015 lows in early AM ; choppy downtrend but look for a bottoming process as market is turning up toward close: IBB at 306 down slightly after reversal XBI down 1.7% to 63.3...
by Raynovich Rod | Sep 25, 2015 | Biopharmaceuticals
After the close 9/25…The bio-bubble has burst. XBI down 6.85%, IBB down 4.91%. Can healthcare sector recover? —– Bull Market Intact But Sentiment Has Turned Negative The severe 20%++ correction in the biotech sector is getting a lot of bearish...
by Raynovich Rod | Sep 21, 2015 | Biopharmaceuticals, Life Science ETF's and Mutual Funds
Update-1… 9/22/15 …Biotech Stocks Trade Down Another Day Biotech stocks were weak tracking NASDAQ which was down 1.5%. The IBB was down 1.49% to $335.40 flat over one month and up 10.57% YTD. The August low was $325 and the IBB is 16% off July 20 highs....
